Cyclacel Pharmaceuticals Stock Technical Analysis
| CYCC Stock | USD 0.41 0.06 17.14% |
As of the 2nd of December, Cyclacel Pharmaceuticals shows the risk adjusted performance of (0.11), and Mean Deviation of 5.31. Cyclacel Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Cyclacel Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cyclacel, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CyclacelCyclacel |
Cyclacel Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 12.25 | Hold | 1 | Odds |
Most Cyclacel analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cyclacel stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cyclacel Pharmaceuticals, talking to its executives and customers, or listening to Cyclacel conference calls.
Cyclacel Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Cyclacel Pharmaceuticals Technical Analysis
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Cyclacel Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Cyclacel Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Cyclacel Pharmaceuticals. You can use it to identify possible trend reversals for Cyclacel Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Cyclacel Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Cyclacel Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Cyclacel Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.01 , which may suggest that Cyclacel Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 7.56, which is the sum of squared deviations for the predicted Cyclacel Pharmaceuticals price change compared to its average price change.About Cyclacel Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cyclacel Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cyclacel Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cyclacel Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Cyclacel Pharmaceuticals. By analyzing Cyclacel Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cyclacel Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cyclacel Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Dividend Yield | 0.0885 | 0.0929 | Price To Sales Ratio | 6.22 | 5.91 |
Cyclacel Pharmaceuticals December 2, 2024 Technical Indicators
Most technical analysis of Cyclacel help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cyclacel from various momentum indicators to cycle indicators. When you analyze Cyclacel charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (2.03) | |||
| Mean Deviation | 5.31 | |||
| Coefficient Of Variation | (668.15) | |||
| Standard Deviation | 7.89 | |||
| Variance | 62.31 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (1.27) | |||
| Total Risk Alpha | (2.51) | |||
| Treynor Ratio | (2.04) | |||
| Maximum Drawdown | 48.1 | |||
| Value At Risk | (15.66) | |||
| Potential Upside | 12.87 | |||
| Skewness | (0.08) | |||
| Kurtosis | 2.26 |
Complementary Tools for Cyclacel Stock analysis
When running Cyclacel Pharmaceuticals' price analysis, check to measure Cyclacel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuticals is operating at the current time. Most of Cyclacel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclacel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |